InsiderClue
← All stocks

ORASURE TECHNOLOGIES INC

OSUR Net selling
CIK 0001116463 #3731 in the set updated 17 Sep 2026
Bought (120 mo)
$2.35M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$48.10M
$0.00 on a plan · $42.68M straight out of an exercise
Sold at will
$5.41M
25 of 81 sales
Net
−$45.75M
−$3.07M against sales at will

By person

33 insiders · 115 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Michels Douglas A
President & CEO
—
$17.66M (17) scheduled
−$17.66M
660,861
0.9582%
$1.98M
−15.5%
SPAIR RONALD H
COO & CFO
—
$13.64M (11) scheduled
−$13.64M
424,810
0.6159%
$1.27M
+0.4%
Zezzo II Anthony
EVP & BU Lead - Infectious
—
$3.24M (2) scheduled
−$3.24M
227,867
0.3304%
$681.32K
+72.9%
KUNA MARK L
See Remarks
—
$3.13M (15) scheduled
−$3.13M
68,167
0.0988%
$203.82K
−6.6%
JERRETT JACK E
SVP General Counsel & CCO
$85.49K (2)
$2.93M (5) scheduled
−$2.84M
124,555
0.1806%
$372.42K
+143.7%
PRINGLE ROGER L
Director
—
$2.10M (1) scheduled
−$2.10M
208,567
0.3024%
$623.62K
+5.6%
TANG STEPHEN S PHD
President and CEO
$8.56K (1)
$1.25M (6) scheduled
−$1.24M
349,793
0.5072%
$1.05M
+589.8%
LANCASTER RONNY B
Director
$200.00K (1)
$1.33M (2)
−$1.13M
104,782
0.1519%
$313.30K
+64.7%
Celano Michael
Director
$53.92K (1)
$1.08M (4)
−$1.03M
111,823
0.1621%
$334.35K
+20.1%
McGrath Kenneth J
Chief Financial Officer
$855.12K (4)
—
+$855.12K
589,562
0.8548%
$1.76M
—
Patrick Charles W
Director
—
$802.16K (9)
−$802.16K
58,446
0.0847%
$174.75K
−35.0%
SMITH BRIAN
EVP & BU Lead - Molecular
—
$610.84K (6) scheduled
−$610.84K
18,075
0.0262%
$54.04K
−31.9%
EGLINTON MANNER CARRIE
President & CEO
$508.03K (4)
—
+$508.03K
2,190,874
3.18%
$6.55M
—
Weber Kathleen Gallagher
Chief Product Officer
—
$311.82K (2) scheduled
−$311.82K
391,206
0.5672%
$1.17M
+1,395%
Boyd Steven Kyle
Director
$224.75K (3)
—
+$224.75K
163,234
0.2367%
$488.07K
—
Kenny John P.
Director
$151.22K (1)
—
+$151.22K
204,598
0.2967%
$611.75K
—
Aspinall Mara G.
Director
$96.30K (2)
—
+$96.30K
178,758
0.2592%
$534.49K
+257.8%
Cuca Roberto
CFO
$90.31K (5)
—
+$90.31K
114,815
0.1665%
$343.30K
+701.8%
Gagliano Nancy J
Director
$53.91K (3)
—
+$53.91K
185,055
0.2683%
$553.31K
—
Marmora Lelio
Director
$21.42K (1)
—
+$21.42K
148,460
0.2153%
$443.90K
—
Anthony Michele Marie
SVP Finance & CAO
—
$11.43K (1) scheduled
−$11.43K
185,788
0.2694%
$555.51K
+3,642%
WATSON DOUGLAS G
Director
—
—
—
188,032
0.2726%
$562.22K
−4.5%
Shulkin David
Director
—
—
—
126,335
0.1832%
$377.74K
—
Nibauer Lisa
President of Diagnostics
—
—
—
123,479
0.1790%
$369.20K
—
McMahon Robert W.
Director
—
—
—
123,137
0.1785%
$368.18K
—
Gleason Scott
Interim CFO/SVP IR
—
—
—
96,509
0.1399%
$288.56K
+372.2%
Gallagher Agnieszka
General Counsel & CCO
—
—
—
90,584
0.1313%
$270.85K
—
Datin James A
Director
—
—
—
82,146
0.1191%
$245.62K
—
Bertrand John D.
Director
—
—
—
79,767
0.1157%
$238.50K
—
HOBBS EAMONN P
Director
—
—
—
61,452
0.0891%
$183.74K
+425.2%
REED MICHAEL
SVP R&D and CSO
—
—
—
49,217
0.0714%
$147.16K
+154.4%
Whitaker Anne Clem
Director
—
—
—
23,840
0.0346%
$71.28K
—
SARIN ARADHANA
Director
—
—
—
16,865
0.0245%
$50.43K
—

Individual transactions

25
Insider
Date
Role
Action
Shares
Price
Amount
Weber Kathleen Gallagher
23 Dec 2020
EVP & BU Lead - Molecular
Sell
10,000
$11.76
$117.60K
Patrick Charles W
27 Aug 2018
Director
Sell
8,000
$16.29
$130.32K
Michels Douglas A
4 Oct 2017
President & CEO
Sell
22,923
$23.00
$527.23K
Michels Douglas A
29 Sep 2017
President & CEO
Sell
25,000
$22.55
$563.71K
Patrick Charles W
30 Aug 2017
Director
Sell
1,000
$20.11
$20.11K
SMITH BRIAN
22 Aug 2017
SEE REMARKS
Sell
1,075
$21.12
$22.70K
SMITH BRIAN
22 Aug 2017
SEE REMARKS
Sell
2,000
$21.08
$42.16K
KUNA MARK L
7 Aug 2017
SVP & Controller
Sell
15,000
$21.32
$319.80K
Patrick Charles W
30 May 2017
Director
Sell
6,666
$15.15
$100.99K
LANCASTER RONNY B
26 May 2017
Director
Sell
74,684
$14.73
$1.10M
Celano Michael
5 May 2017
Director
Sell
44,962
$14.95
$672.18K
Patrick Charles W
5 May 2017
Director
Sell
745
$14.96
$11.15K
Patrick Charles W
5 May 2017
Director
Sell indirect
9,255
$14.96
$138.45K
TANG STEPHEN S PHD
21 Mar 2017
Director
Sell
220
$12.00
$2.64K
TANG STEPHEN S PHD
2 Mar 2017
Director
Sell
6,100
$12.02
$73.35K
Patrick Charles W
28 Feb 2017
Director
Sell
13,880
$11.27
$156.41K
Patrick Charles W
28 Feb 2017
Director
Sell indirect
5,650
$11.30
$63.85K
Patrick Charles W
27 Feb 2017
Director
Sell
1,003
$11.35
$11.38K
Patrick Charles W
27 Feb 2017
Director
Sell
15,000
$11.30
$169.50K
SPAIR RONALD H
16 Feb 2017
COO & CFO
Sell indirect
50,000
$11.12
$555.78K
Celano Michael
9 Feb 2017
Director
Sell
10,000
$10.06
$100.60K
KUNA MARK L
9 Feb 2017
SVP & Controller
Sell
15,000
$10.00
$150.00K
TANG STEPHEN S PHD
9 Feb 2017
Director
Sell
12,641
$10.23
$129.29K
SPAIR RONALD H
17 Jan 2017
COO & CFO
Sell indirect
3,341
$8.71
$29.10K
Michels Douglas A
26 Sep 2016
President & CEO
Sell
25,000
$8.22
$205.53K
Show all 115 transactions →

What was left out

Form 4 filings counted 298
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 56
Sales at will 25
Transactions with no price 0
Shares from compensation/vesting 12,001,450
Sales filed before the plan box existed 25
History held since 28 Sep 2016